公司概覽
業務類別 Medical Devices
業務概覽 Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
公司地址 100 Nagog Park, Acton, MA, USA, 01720
電話號碼 +1 978 600-7000
傳真號碼 --
公司網頁 https://www.insulet.com
員工數量 5400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Flavia H. Pease Executive Vice President, Chief Financial Officer -- 18/02/2026
Mr. Prem Singh Senior Vice President, Global Operations -- 29/04/2025
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer -- 18/02/2026
Mr. Dan Manea Senior Vice President and Chief Human Resources Officer -- 29/04/2025
Ms. Lauren D. Budden Group Vice President, Chief Accounting Officer and Controller 美元 407.00K 29/04/2025
Mr. Eric Benjamin Executive Vice President, Chief Product and Customer Experience Officer 美元 540.39K 29/04/2025
Mr. John W. Kapples Senior Vice President and General Counsel 美元 500.96K 29/04/2025
Mr. Amit Guliani Group Vice President, Software Engineering and Acting Chief Technology Officer -- 17/03/2025
Ms. Laetitia Cousin Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Timothy C. Stonesifer Independent Director 18/02/2026
Dr. Luciana Borio, M.D. Independent Director 18/02/2026
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer 18/02/2026
Dr. Wayne A.I. Frederick, M.D. Independent Director 18/02/2026
Dr. Jessica Hopfield, PhD Director 18/02/2026
Mr. Timothy John Scannell Chairman of the Board 18/02/2026
Mr. Michael R. Minogue Independent Director 18/02/2026
Ms. Elizabeth H. Weatherman Independent Director 18/02/2026
Mr. Robbie Huffines Director 18/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:56)
代號 名稱 佔比% 持有日期
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.01%27/02/2026
FTQIFirst Trust Nasdaq BuyWrite Income ETF0.01%26/02/2026
CSMProShares Large Cap Core Plus0.01%27/02/2026
FEXFirst Trust Large Cap Core AlphaDEX® ETF0.01%26/02/2026
QGRWWisdomTree U.S. Quality Growth ETF0.01%27/02/2026
AGNGGlobal X Aging Population ETF0.01%27/02/2026
USXFiShares® ESG Advanced MSCI USA ETF0.01%28/02/2026
XYLDGlobal X S&P 500® Covered Call ETF0.01%27/02/2026
CATHGlobal X S&P 500® Catholic Values ETF0.01%27/02/2026
PTLInspire 500 ETF0.01%27/02/2026
RWLInvesco S&P 500 Revenue ETF0.01%27/02/2026
UPROProShares UltraPro S&P5000.005%27/02/2026
RSPAInvesco S&P 500 Eq Wght Inc Adv ETF0.005%27/02/2026
TPLCTimothy Plan US Large/Mid Cap Core ETF0.004%27/02/2026
IYYiShares Dow Jones US ETF0.004%28/02/2026
SPYXSttStrt® SPDR® S&P®500FsslFulRsrvFreeETF0.004%27/02/2026
GPIXGoldman Sachs S&P 500 Premium Inc ETF0.004%27/02/2026
DTECALPS Disruptive Technologies ETF0.004%27/02/2026
SDGiShares MSCI Global Sust Dev Goals ETF0.004%28/02/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.